PubMed Health⌕ Search

Biomedical subjects

Emilio Mordini

Publications and source records attributed to Emilio Mordini.

7 recordsLinked to original sources
PubMed2006

The Budapest Meeting 2005 intensified networking on ethics of science: the case of reproductive cloning, germline gene therapy and human dignity.

This paper reports on the meeting of the Sounding Board of the EU Reprogenetics Project that was held in Budapest, Hungary, 6-9 November 2005. The Reprogenetics Project runs from 2004 until 2007 and has a brief to study the ethical aspects of human reproductive cloning and germline gene therapy. Discussions during The Budapest Meeting are reported in depth in this paper as well as the initiatives to involve the participating groups and others in ongoing collaborations with the goal of forming an integrated network of European resources in the fields of ethics of science.

Cloning, Organism↗
PubMed2004

Ethical considerations on pharmacogenomics.

Pharmacogenetics offers the prospect of an era of safer and more effective drugs, as well as more individualized use of drug therapies. The effect of human genetic variance on responses to therapy will influence drug-development clinical trials and the use of products in clinical practice. It also promises to raise new ethical challenges, in particular in the fields of research and therapy. Last but not least, pharmacogenetics is likely to fulfil the old dream of an individualised medicine, but in a totally unexpected way.

Health Policy↗
PubMed2004

Peptide vaccines in immunocontraception.

Vaccines have been used successfully to treat and eradicate infectious diseases; this has encouraged a major drive towards development of contraceptive vaccines (immunocontraception) as an additional method against rising human and animal populations. Despite three decades worth of research in this field, there are no licensed human contraceptive vaccines and less than ten for use in animals. The development of peptide antifertility vaccines has had a substantial impact on improving safety and specificity of immunogens, but has resulted in efficacy problems. Innovative strategies have been developed to overcome these problems.

Animals↗
PubMed2002

[Weakness of will].

Addictive behaviours raise the issue how it is possible that a free agent is not able to act according to his own will. Indeed an agent can be defined as "addicted", to a substance or a behaviour, only when he does not succeed in discontinuing despite his will. Namely in the very idea of addiction it is involved the idea of weakness of will. The problem of weakness of will is one of the most intriguing problems posed by human spirit. This paper intends to show some of its manifestations.

Humans↗